短期抗微生物治疗与急性胆管炎中的细菌耐药性的关联:回顾性队列研究
Sakue Masuda1, Ryuhei Jinushi2, Yoshinori Imamura3
1Gastroenterology, Shonan Kamakura General Hospital, Kamakura, Japan.
Endoscopy international open
|February 29, 2024
概括
在治疗急性胆道炎的内镜逆行胆道松造影术 (ERCP) 后短期使用抗生素可能会减少耐药细菌的发展. 这项研究表明,三天的抗生素疗程可以抑制抗菌素耐药性.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 抗菌素耐药性是一个越来越令人担忧的问题,特别是长期使用抗生素.
- 抗生素治疗持续时间和急性胆道炎的细菌耐药性之间的关系尚未得到充分研究.
- 这项研究调查了短期抗生素给药对抑制急性胆管炎细菌耐药性的影响.
研究的目的:
- 为了确定短期抗微生物治疗是否抑制急性胆道炎患者的细菌耐药性.
- 鉴定胆道排水程序后与耐药病原体的发展相关的风险因素.
- 为了评估抗生素持续时间和抗菌素耐药性之间的关联,在内镜逆行胆血管细胞造影 (ERCP) 后进行.
主要方法:
- 一项回顾性观察性研究包括89名患有急性胆管炎的患者,这些患者经历了成功的胆管排水.
- 根据病原体对初始抗微生物药物的敏感性,患者在复发时被分为耐药和易感组.
- 多变量分析检查了发生细菌耐药性的风险因素,包括ERCP后3天内使用抗生素.
主要成果:
- 两组之间没有观察到患者背景或ERCP发现的显著差异.
- 在ERCP后3天内使用抗生素与较低发展细菌耐药性的风险显著相关 (OR,0.17;P=0.01).
- 这表明短期使用抗生素对抗耐药性发展有保护作用.
结论:
- 在急性胆道炎中,在ERCP后3天内服用抗微生物药物可能会抑制耐药细菌的出现.
- 短期抗生素治疗似乎是减轻这种患者群体抗菌素耐药性的可行策略.
- 进一步的研究可以探索最佳的抗生素持续时间,以平衡疗效和耐药性预防.
更多相关视频
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
26.2K
10:05Bile Salt-induced Biofilm Formation in Enteric Pathogens: Techniques for Identification and Quantification
Published on: May 6, 2018
12.6K
相关概念视频
Chronic Bowel Disorders: Introduction
450
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
450
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Antibiotic Selection
53.5K
Overview
53.5K
